Is BriaCell Therapeutics Corp. (BCT.TO) a Buy, Sell, or Hold?
TSX : BCT.TO
BriaCell Therapeutics Corp.
$5.26 CAD
-$0.08 (-1.5%)
- Volume
- 1.8K
- Average Volume
- 13.26K
- Market Capitalization
- $9.91M
- P/E Ratio
- -0.31
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $20.40
- Year Low
- $3.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.07
| Source | Headline |
|---|---|
|
BriaCell Therapeutics Announces Pricing of Offering
PHILADELPHIA and VANCOUVER, British Columbia, May 31, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL, BCTXZ) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced the pricing of a best-efforts offering of 1,449,300 common shares. globenewswire.com - 2026-05-31 19:59:35 |
